Author

Paul Bowker

Observed name: P Bowker

Observed institution: The University of Melbourne

OpenAlex ID: A5013901613

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

A clinical study of the allotransplantation of unerupted maxillary canines*

1973 · Peter Reade, Alan Mansour, et al. · Australian Dental Journal · 8

Burns from a blunt plaster saw blade.

1986 · J J Henderson, W A Wallace, et al. · PubMed · 2

A conservative surgical approach to the correction of irritational hyperplasias caused by dentures

1973 · Peter Reads, Paul Bowker · British Journal of Oral Surgery · 1

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 7

Citation count: 103

H-index: 4

I10-index: 3